Search research articles
Contact Us
Filters
Showing results (51-60 of 158) with videos related to
Page
of 16
Sort By:
FEBS Letters
|
September 6, 1993
Tamoxifen and related compounds decrease membrane fluidity in liposomes. Mechanism for the antioxidant action of tamoxifen and relevance to its anticancer and cardioprotective actions?
H Wiseman, P Quinn, B Halliwell
Biotechnology & Genetic Engineering Reviews
|
January 1, 1997
Novel bioconversions for the production of designer antioxidant and colourant flavonoids using polyphenol oxidases
T Ridgway, G Tucker, H Wiseman
Journal of Medicinal Chemistry
|
October 1, 1971
Antiinflammatory 3,4-dihydro-2-alkyl-3-oxo-2H-1,2-benzothiazine-4-carboxamide 1,1-dioxides
J G Lombardino, E H Wiseman
Biochemical Society Transactions
|
December 1, 1989
Observation and significance of growth inhibition of Saccharomyces cerevisiae (A224A) by the anti-oestrogen drug tamoxifen
H Wiseman, M Cannon, H R Arnstein
Trends in Biotechnology
|
November 11, 1999
Bioclean effluents or bioclean products?
A Wiseman, T J Ridgway, H Wiseman
FEBS Letters
|
August 7, 1995
Nitric oxide and oxygen radicals: a question of balance
V Darley-Usmar, H Wiseman, B Halliwell
Biochemical Society Transactions
|
December 1, 1990
The protective effect of ascorbate on the inhibition of growth, RNA and protein synthesis by tamoxifen in yeast is time dependent
H Wiseman, M Cannon, H R Arnstein
Breast Cancer Research and Treatment
|
January 1, 1994
Antioxidant benefits of tamoxifen therapy for breast cancer?
H Wiseman, C Rice-Evans, B Halliwell
Biochemical Society Transactions
|
October 1, 1990
Tamoxifen inhibits RNA and protein synthesis simultaneously in Saccharomyces cerevisiae: partial protection by antioxidants
H Wiseman, M Cannon, H R Arnstein
Methods in Molecular Biology (Clifton, N.J.)
|
July 24, 2017
Nanofluidic Allele-Specific Digital PCR Method for Quantifying IDH1 and IDH2 Mutation Burden in Acute Myeloid Leukemia
Daniel H Wiseman, Tim C P Somervaille
Page
of 16
Search research articles
Search
Showing results (51-60 of 158) with videos related to
Sort By:
Page
of 16
FEBS Letters
|
September 6, 1993
Tamoxifen and related compounds decrease membrane fluidity in liposomes. Mechanism for the antioxidant action of tamoxifen and relevance to its anticancer and cardioprotective actions?
H Wiseman, P Quinn, B Halliwell
Biotechnology & Genetic Engineering Reviews
|
January 1, 1997
Novel bioconversions for the production of designer antioxidant and colourant flavonoids using polyphenol oxidases
T Ridgway, G Tucker, H Wiseman
Journal of Medicinal Chemistry
|
October 1, 1971
Antiinflammatory 3,4-dihydro-2-alkyl-3-oxo-2H-1,2-benzothiazine-4-carboxamide 1,1-dioxides
J G Lombardino, E H Wiseman
Biochemical Society Transactions
|
December 1, 1989
Observation and significance of growth inhibition of Saccharomyces cerevisiae (A224A) by the anti-oestrogen drug tamoxifen
H Wiseman, M Cannon, H R Arnstein
Trends in Biotechnology
|
November 11, 1999
Bioclean effluents or bioclean products?
A Wiseman, T J Ridgway, H Wiseman
FEBS Letters
|
August 7, 1995
Nitric oxide and oxygen radicals: a question of balance
V Darley-Usmar, H Wiseman, B Halliwell
Biochemical Society Transactions
|
December 1, 1990
The protective effect of ascorbate on the inhibition of growth, RNA and protein synthesis by tamoxifen in yeast is time dependent
H Wiseman, M Cannon, H R Arnstein
Breast Cancer Research and Treatment
|
January 1, 1994
Antioxidant benefits of tamoxifen therapy for breast cancer?
H Wiseman, C Rice-Evans, B Halliwell
Biochemical Society Transactions
|
October 1, 1990
Tamoxifen inhibits RNA and protein synthesis simultaneously in Saccharomyces cerevisiae: partial protection by antioxidants
H Wiseman, M Cannon, H R Arnstein
Methods in Molecular Biology (Clifton, N.J.)
|
July 24, 2017
Nanofluidic Allele-Specific Digital PCR Method for Quantifying IDH1 and IDH2 Mutation Burden in Acute Myeloid Leukemia
Daniel H Wiseman, Tim C P Somervaille
Page
of 16